Skip to main content

H.R. 6342

Referred to Committee

SBIC Capital Infusion Act of 2020

Introduced 3/23/2020•116th Congress•House

Latest Action

Referred to the House Committee on Small Business.

3/23/2020 • House

Summary

SBIC Capital Infusion Act of 2020

This bill provides economic assistance to small businesses affected by COVID-19 (i.e., coronavirus disease 2019), and it reestablishes the New Markets Venture Capital Program.

Specifically, the bill provides additional leverage for small business investment companies (SBICs) by requiring the Small Business Administration (SBA), when calculating the maximum amount of outstanding leverage made available to SBICs, to exclude a certain amount of outstanding leverage to small businesses affected by COVID-19. Any excluded amounts must be used solely for working capital purposes.

The bill also reestablishes the New Markets Venture Capital Program, through which the SBA, in partnership with investment companies, encourages developmental venture capital investment in small businesses located in low-income areas.

Introduced in House • 3/23/2020

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Commerce
Business investment and capitalCardiovascular and respiratory healthEmergency medical services and trauma careInfectious and parasitic diseasesSmall business

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (1)

Sponsor

R[
Rep. Davids, Sharice [D-KS-3]

Democrat • KS-3

Sponsored 3/23/2020

No cosponsors yet

Cosponsors may be added as the bill moves through Congress

Bill Journey

Originated in the House

Introduced

March 23, 2020

Referred to the House Committee on Small Business.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House3/23/2020

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors0